AFG206
AFG206 is a novel, first-generation type II FLT3 inhibitor for research use. It potently targets both wild-type and mutant FLT3, showing efficacy in cellular assays and in vivo models of acute myeloid leukemia (AML) . This compound is a valuable tool for investigating FLT3-driven oncogenesis and therapeutic strategies.
Product Specifications
CAS Number
630122-37-1
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Smiles
O (C1=CC=C (NC (NC2=CC=C (CC) C=C2) =O) C=C1) C=3C=CN=CC3
Molecular Formula
C20H19N3O2
Molecular Weight
333.38
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2403540-01 0.05 mg
CLDN3/Claudin 3 Rabbit anti-Human Polyclonal Antibody
Sign In for Pricing
View Details MBS2403540-02 5x 0.05 mg
CLDN3/Claudin 3 Rabbit anti-Human Polyclonal Antibody
Sign In for Pricing
View Details 031749-APC 200 µL
AKT1 (S129) (AKT1, PKB, RAC, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha) (APC) discontinued
Sign In for Pricing
View Details 
GTR10334062 96 Well
Mouse Acetylcholine receptor subunit β (CHRNB1) ELISA Kit
Sign In for Pricing
View Details 